{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:40:23Z","timestamp":1790858423643,"version":"4.1.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1093\/carcin\/bgr135","type":"journal-article","created":{"date-parts":[[2011,7,20]],"date-time":"2011-07-20T00:44:36Z","timestamp":1311122676000},"page":"1450-1458","source":"Crossref","is-referenced-by-count":61,"title":["Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL"],"prefix":"10.1093","volume":"32","author":[{"given":"Vitaliy O.","family":"Kaminskyy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Surova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Vaculova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Zhivotovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,7,18]]},"reference":[{"key":"key\n\t\t\t\t20170521000435_bib1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1200\/JCO.1990.8.3.396","article-title":"Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation","volume":"8","author":"Johnson","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20170521000435_bib2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1200\/JCO.1995.13.5.1215","article-title":"Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years\u2013an analysis of 1,714 consecutive patients","volume":"13","author":"Lassen","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"key\n\t\t\t\t20170521000435_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86397","article-title":"Differential hepatocyte toxicity of recombinant Apo2L\/TRAIL versions","volume":"7","author":"Lawrence","year":"2001","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170521000435_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1074-7613(00)80212-5","article-title":"Apo2L\/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5","volume":"12","author":"Kischkel","year":"2000","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20170521000435_bib5","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/23730","article-title":"Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis","volume":"400","author":"Yin","year":"1999","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170521000435_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1006\/bbrc.1999.1191","article-title":"Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma","volume":"262","author":"Joseph","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"key\n\t\t\t\t20170521000435_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.cdd.4401157","article-title":"Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation","volume":"10","author":"Hopkins-Donaldson","year":"2003","journal-title":"Cell Death Differ."},{"key":"key\n\t\t\t\t20170521000435_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1476-4598-9-87","article-title":"Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL","volume":"9","author":"Vaculova","year":"2010","journal-title":"Mol. Cancer"},{"key":"key\n\t\t\t\t20170521000435_bib9","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1038\/sj.onc.1204750","article-title":"Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer","volume":"20","author":"Fulda","year":"2001","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170521000435_bib10","first-page":"1122","article-title":"Induction of caspase 8 by interferon gamma renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1\/TR2 also contributes to TRAIL resistance in NB","volume":"63","author":"Yang","year":"2003","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521000435_bib11","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1038\/onc.2009.161","article-title":"Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8","volume":"28","author":"H\u00e4cker","year":"2009","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170521000435_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4161\/cbt.1.1.45","article-title":"Differential inactivation of caspase-8 in lung cancers","volume":"1","author":"Shivapurkar","year":"2002","journal-title":"Cancer Biol. Ther."},{"key":"key\n\t\t\t\t20170521000435_bib13","doi-asserted-by":"crossref","first-page":"8510","DOI":"10.1038\/sj.onc.1205941","article-title":"Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification","volume":"21","author":"Shivapurkar","year":"2002","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170521000435_bib14","first-page":"662","article-title":"Histone deacetylase inhibitors: a new class of potential therapeutic agents for cancer treatment","volume":"8","author":"Richon","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170521000435_bib15","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1182\/blood-2006-03-009142","article-title":"Phase 1\/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia","volume":"108","author":"Garcia-Manero","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170521000435_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170521000435_bib17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20170521000435_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/PL00007399","article-title":"APO2L\/TRAIL expression in human brain tumors","volume":"99","author":"Nakamura","year":"2000","journal-title":"Acta Neuropathol."},{"key":"key\n\t\t\t\t20170521000435_bib19","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.4049\/jimmunol.166.9.5407","article-title":"The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells","volume":"166","author":"Liu","year":"2001","journal-title":"J. Immunol."},{"key":"key\n\t\t\t\t20170521000435_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.lungcan.2007.11.005","article-title":"TRAIL-induced survival and proliferation of SCLC cells is mediated by ERK and dependent on TRAIL-R2\/DR5 expression in the absence of caspase-8","volume":"60","author":"Belyanskaya","year":"2008","journal-title":"Lung Cancer"},{"key":"key\n\t\t\t\t20170521000435_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/5047","article-title":"Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer","volume":"21","author":"Cameron","year":"1999","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170521000435_bib22","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ng892","article-title":"A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer","volume":"31","author":"Suzuki","year":"2002","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170521000435_bib23","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1158\/1078-0432.CCR-08-1247","article-title":"Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers","volume":"14","author":"Braiteh","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170521000435_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/excr.2000.5080","article-title":"The human histone deacetylase family","volume":"262","author":"Gray","year":"2001","journal-title":"Exp. Cell Res."},{"key":"key\n\t\t\t\t20170521000435_bib25","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J."},{"key":"key\n\t\t\t\t20170521000435_bib26","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","article-title":"The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2","volume":"22","author":"Kr\u00e4mer","year":"2003","journal-title":"EMBO J."},{"key":"key\n\t\t\t\t20170521000435_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/77023","article-title":"DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci","volume":"25","author":"Rountree","year":"2000","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170521000435_bib28","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng0708-812","article-title":"HDAC2 deficiency and histone acetylation","volume":"40","author":"Ree","year":"2008","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170521000435_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/1535-7163.425.3.4","article-title":"The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells","volume":"3","author":"Zhang","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"key\n\t\t\t\t20170521000435_bib30","first-page":"1273","article-title":"Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells","volume":"2","author":"Rosato","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"key\n\t\t\t\t20170521000435_bib31","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1038\/sj.onc.1208585","article-title":"HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma","volume":"24","author":"Singh","year":"2005","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170521000435_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nm1160","article-title":"Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway","volume":"11","author":"Insinga","year":"2005","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170521000435_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nm1161","article-title":"Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells","volume":"11","author":"Nebbioso","year":"2005","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170521000435_bib34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1593\/neo.04655","article-title":"Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma","volume":"7","author":"Fandy","year":"2005","journal-title":"Neoplasia"},{"key":"key\n\t\t\t\t20170521000435_bib35","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/carcin\/bgh188","article-title":"Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells","volume":"25","author":"Kim","year":"2004","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20170521000435_bib36","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/ijc.21939","article-title":"The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L\/TRAIL","volume":"119","author":"Butler","year":"2006","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20170521000435_bib37","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1038\/sj.onc.1207830","article-title":"Histone deacetylase inhibitors upregulate death receptor 5\/TRAIL-R2 and sensitize apoptosis induced by TRAIL\/APO2-L in human malignant tumor cells","volume":"23","author":"Nakata","year":"2004","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170521000435_bib38","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1158\/0008-5472.CAN-03-2629","article-title":"Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L\/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells","volume":"64","author":"Guo","year":"2004","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170521000435_bib39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1158\/1535-7163.MCT-10-0725","article-title":"Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway","volume":"10","author":"Jane","year":"2011","journal-title":"Mol. Cancer Ther."}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/32\/10\/1450\/17289342\/bgr135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T21:46:46Z","timestamp":1712612806000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgr135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,18]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,7,18]]},"published-print":{"date-parts":[[2011,10]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgr135","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,18]]}}}